XNK Therapeutics receives orphan drug designation from EMA December 15, 2017 For more info: https://news.cision.com/se/xnk-therapeutics-ab/r/svenska-cellterapikandidaten-cellprotect-har-erhallit-sarlakemedelsstatus-for-behandling-av-multipel,c2415694